562 related articles for article (PubMed ID: 23954699)
1. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
[TBL] [Abstract][Full Text] [Related]
2. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.
Stevenson DA; Rudser K; Kunin-Batson A; Fung EB; Viskochil D; Shapiro E; Orchard PJ; Whitley CB; Polgreen LE
J Pediatr Rehabil Med; 2014; 7(2):159-65. PubMed ID: 25096868
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
5. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models.
Simonaro CM; D'Angelo M; Haskins ME; Schuchman EH
Pediatr Res; 2005 May; 57(5 Pt 1):701-7. PubMed ID: 15746260
[TBL] [Abstract][Full Text] [Related]
6. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
[TBL] [Abstract][Full Text] [Related]
7. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
Muenzer J
Mol Genet Metab; 2014 Feb; 111(2):63-72. PubMed ID: 24388732
[TBL] [Abstract][Full Text] [Related]
8. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses.
Simonaro CM; Haskins ME; Schuchman EH
Lab Invest; 2001 Sep; 81(9):1319-28. PubMed ID: 11555679
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator.
Clarke LA
Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v13-8. PubMed ID: 22210665
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal manifestations of mucopolysaccharidoses.
Morishita K; Petty RE
Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v19-25. PubMed ID: 22210666
[TBL] [Abstract][Full Text] [Related]
11. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
Entchev E; Jantzen I; Masson P; Bocart S; Bournique B; Luccarini JM; Bouchot A; Lacombe O; Junien JL; Broqua P; Tallandier M
PLoS One; 2020; 15(5):e0233032. PubMed ID: 32413051
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
13. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidoses and the eye.
Ashworth JL; Biswas S; Wraith E; Lloyd IC
Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
[TBL] [Abstract][Full Text] [Related]
15. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
[TBL] [Abstract][Full Text] [Related]
16. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.
Simonaro CM; D'Angelo M; He X; Eliyahu E; Shtraizent N; Haskins ME; Schuchman EH
Am J Pathol; 2008 Jan; 172(1):112-22. PubMed ID: 18079441
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
[TBL] [Abstract][Full Text] [Related]
19. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses.
Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S
Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
